 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
- | Cellistem-OA (umbilical cord derived-mesenchymal stromal cells) / Cells for Cells
Journal, Stroma: Efficacy of a single dose of cryopreserved human umbilical cord mesenchymal stromal cells for the treatment of knee osteoarthritis:a randomized, controlled, double-blind pilot study. (Pubmed Central) - Jan 13, 2025
This pilot study revealed that a single dose of CellistemOA is safe and superior to the active comparator in knee OA at 1-year of follow-up, making it a compelling therapeutic alternative to treat symptomatic OA patients.
- | Cellistem-OA (umbilical cord derived-mesenchymal stromal cells) / Cells for Cells
New P1 trial: Intra-articular Injection of MSC-derived Exosomes in Knee Osteoarthritis (ExoOA-1) (clinicaltrials.gov) - Sep 27, 2021
P1, N=10, Not yet recruiting, Sponsor: Francisco Espinoza
- | Cellistem-OA (umbilical cord derived-mesenchymal stromal cells) / Cells for Cells
New P1/2 trial: Cell Therapy With Cellistem-OA for Symptomatic Knee Osteoarthritis (clinicaltrials.gov) - Apr 27, 2021
P1/2, N=30, Not yet recruiting, Sponsor: Fundaci
- | Cellistem-OA (umbilical cord derived-mesenchymal stromal cells) / Cells for Cells
New P1 trial: CLT-OA1: Dose-escalation of Cellistem-OA in Patients With Knee Osteoarthritis (clinicaltrials.gov) - Jan 18, 2019
P1, N=24, Recruiting, Sponsor: Universidad de los Andes, Chile
- | Durolane (sodium hyaluronate) / Bioventus, NN1213 / Novo Nordisk, Cellistem-OA (umbilical cord derived-mesenchymal stromal cells) / Cells for Cells
Trial completion, Trial completion date, Stroma: A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis (clinicaltrials.gov) - Dec 26, 2018
P1/2, N=30, Completed, Sponsor: Francisco Espinoza, MD
This pilot study revealed that a single dose of CellistemOA is safe and superior to the active comparator in knee OA at 1-year of follow-up, making it a compelling therapeutic alternative to treat symptomatic OA patients. Active, not recruiting --> Completed | Trial completion date: Jan 2017 --> Apr 2017
- Durolane (sodium hyaluronate) / Bioventus, Cellistem-OA (umbilical cord derived-mesenchymal stromal cells) / Cells for Cells
Enrollment closed, Stroma: A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis (clinicaltrials.gov) - Sep 27, 2016
P1/2, N=30, Active, not recruiting, Sponsor: Francisco Espinoza, MD
Active, not recruiting --> Completed | Trial completion date: Jan 2017 --> Apr 2017 Recruiting --> Active, not recruiting
- Durolane (sodium hyaluronate) / Bioventus, Cellistem-OA (umbilical cord derived-mesenchymal stromal cells) / Cells for Cells
New P1/2 trial, Stroma: A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis (clinicaltrials.gov) - Oct 22, 2015
P1/2, N=30, Recruiting, Sponsor: Francisco Espinoza, MD